|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01255 TATA HEALTH
Nominal 
2.100 0.000 (0.000%) | 2026/06 - Interim HKD(K$) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | -- | (16,985) | 1,235 | 37,788 | 13,005 |
| Net Cash from / (used in) Investing Activities | -- | 15,379 | (2,096) | (8,172) | 7,928 |
| Net Cash from / (used in) Financing Activities | -- | (3,473) | (15,699) | (22,830) | (13,965) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (5,079) | (16,560) | 6,786 | 6,968 |
| Cash & Cash Equivalents at beginning of period | -- | 22,999 | 40,002 | 33,649 | 26,743 |
| Effect of Foreign Exchange Rate Changes | -- | 0 | 0 | (433) | (62) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 17,920 | 23,442 | 40,002 | 33,649 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -290 |
| %Change | -- |
| EPS / (LPS) | HKD -0.001 |
| NBV Per Share ($) | HKD -0.227 |